Platelet Transfusion in ITP

Emergency/Life-Threatening Bleeding

The American Society of Hematology recommends platelet transfusions in combination with IVIg and high-dose corticosteroids for life-threatening hemorrhage in ITP patients 1, 2, 3, 4
Initiate platelet transfusions immediately in conjunction with IVIg and high-dose corticosteroids for life-, limb-, or sight-threatening hemorrhage in ITP patients 1, 2, 3, 4, 5
Transfuse platelets frequently, as case reports describe successful regimens ranging from every 30 minutes to every 8 hours, often with continuous IVIg infusion 1, 2, 3
The platelet increment will be short-lived due to ongoing immune destruction, but transfusions can provide temporary hemostasis while other therapies take effect 1, 2, 3
IVIg has the most rapid onset of action (grade 2B evidence) among standard ITP therapies and should be prioritized alongside corticosteroids 1, 2, 3, 4

The American Society of Hematology does not recommend platelet transfusions for asymptomatic ITP patients regardless of platelet count 5, 6
Platelet transfusions are not recommended for stable ITP patients without active bleeding, even with very low platelet counts 7
Routine prophylaxis in ITP is not recommended, as it differs fundamentally from bone marrow failure thrombocytopenia where prophylactic transfusions at 10 × 10⁹/L are standard 7

Platelet transfusions are relatively contraindicated in thrombotic thrombocytopenic purpura (TTP) due to thrombosis risk 7
ITP differs from cancer/chemotherapy-induced thrombocytopenia where prophylactic transfusions at 10 × 10⁹/L reduce hemorrhage risk 7
Transfused platelets in ITP are rapidly destroyed by the same immune mechanism affecting native platelets, making routine transfusion ineffective 1, 2, 3

Recombinant factor VIIa (rFVIIa) can stop bleeding in critical ITP patients, though thrombosis risk exists 1, 2, 3, 4
Antifibrinolytic agents (aminocaproic acid, tranexamic acid) may be considered as adjuncts, but efficacy is unproven 1, 2, 3, 4
Emergency splenectomy is considered heroic with significant risks, but may be reported in truly life-threatening cases, usually with platelet transfusion 1, 2, 3, 4